Amanda St. John, APRN, AGPCNP-C

NPI: 1447809256
Total Payments
$461.78
2022 Payments
$16.93
Companies
9
Transactions
22
Medicare Patients
1,209
Medicare Billing
$98,438

Payment Breakdown by Category

Food & Beverage$361.83 (78.4%)
Education$99.95 (21.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $361.83 21 78.4%
Education $99.95 1 21.6%

Top Paying Companies

Company Total Records Latest Year
AbbVie Inc. $169.22 10 $0 (2021)
Janssen Biotech, Inc. $122.68 3 $0 (2021)
Intercept Pharmaceuticals, Inc. $40.81 2 $0 (2021)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $32.55 2 $0 (2021)
Takeda Pharmaceuticals U.S.A., Inc. $21.99 1 $0 (2021)
Celgene Corporation $19.98 1 $0 (2021)
PFIZER INC. $19.62 1 $0 (2021)
Ferring Pharmaceuticals Inc. $18.00 1 $0 (2021)
Masimo Corporation $16.93 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $16.93 1 Masimo Corporation ($16.93)
2021 $444.85 21 AbbVie Inc. ($169.22)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/23/2022 Masimo Corporation RAS-45 RRa Adult/Pediatric Acoustic Respiration Sensor (Device), rainbow SET, EMMA Food and Beverage In-kind items and services $16.93 General
Category: Devices
09/28/2021 AbbVie Inc. LINZESS (Drug), CREON Food and Beverage In-kind items and services $14.98 General
Category: GASTROENTEROLOGY
09/28/2021 AbbVie Inc. LINZESS (Drug), CREON Food and Beverage In-kind items and services $14.25 General
Category: GASTROENTEROLOGY
09/11/2021 AbbVie Inc. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $16.60 General
Category: GASTROENTEROLOGY
08/18/2021 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $19.98 General
Category: Neuroscience
08/12/2021 AbbVie Inc. HUMIRA (Biological) Food and Beverage In-kind items and services $14.82 General
Category: IMMUNOLOGY
07/08/2021 AbbVie Inc. LINZESS (Drug), CREON Food and Beverage In-kind items and services $5.39 General
Category: GASTROENTEROLOGY
06/10/2021 AbbVie Inc. LINZESS (Drug), CREON Food and Beverage In-kind items and services $15.69 General
Category: GASTROENTEROLOGY
05/29/2021 AbbVie Inc. HUMIRA (Biological) Food and Beverage In-kind items and services $24.16 General
Category: IMMUNOLOGY
05/26/2021 AbbVie Inc. LINZESS (Drug), CREON Food and Beverage In-kind items and services $6.04 General
Category: GASTROENTEROLOGY
05/25/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), TRULANCE Food and Beverage In-kind items and services $16.87 General
Category: Gastroenterology
05/14/2021 Ferring Pharmaceuticals Inc. CIMZIA (Drug) Food and Beverage In-kind items and services $18.00 General
Category: GASTROENTEROLOGY
05/07/2021 Takeda Pharmaceuticals U.S.A., Inc. MOTEGRITY (Drug) Food and Beverage In-kind items and services $21.99 General
Category: INTERNAL MEDICINE
04/19/2021 Janssen Biotech, Inc. STELARA (Biological) Education In-kind items and services $99.95 General
Category: Immunology
04/19/2021 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $5.48 General
Category: Immunology
03/31/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.68 General
Category: Gastroenterology
03/26/2021 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $17.25 General
Category: Immunology
03/10/2021 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $19.26 General
Category: HEPATOLOGY GASTROENTEROLOGY
03/05/2021 AbbVie Inc. HUMIRA (Biological) Food and Beverage In-kind items and services $27.67 General
Category: IMMUNOLOGY
02/12/2021 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $19.62 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
01/29/2021 AbbVie Inc. HUMIRA (Biological) Food and Beverage In-kind items and services $29.62 General
Category: IMMUNOLOGY
01/20/2021 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $21.55 General
Category: HEPATOLOGY GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 179 249 $83,290 $18,745
2022 3 139 237 $76,495 $16,527
2021 4 352 448 $74,252 $26,052
2020 4 539 749 $121,640 $37,114
Total Patients
1,209
Total Services
1,683
Medicare Billing
$98,438
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 63 116 $38,234 $9,286 24.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 36 37 $21,800 $4,316 19.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 52 66 $15,061 $3,321 22.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 15 15 $6,225 $1,317 21.2%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 13 15 $1,970 $505.65 25.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 85 173 $55,187 $11,874 21.5%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 34 36 $15,120 $3,303 21.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 20 28 $6,188 $1,350 21.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 221 306 $42,840 $16,048 37.5%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 68 68 $14,280 $4,320 30.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 47 58 $11,948 $4,113 34.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 16 16 $5,184 $1,571 30.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 334 532 $74,480 $22,834 30.7%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 113 113 $23,730 $6,705 28.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 75 87 $17,922 $6,020 33.6%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 17 17 $5,508 $1,556 28.2%

About Amanda St. John, APRN, AGPCNP-C

Amanda St. John, APRN, AGPCNP-C is a Registered Nurse healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2019. The National Provider Identifier (NPI) number assigned to this provider is 1447809256.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda St. John, APRN, AGPCNP-C has received a total of $461.78 in payments from pharmaceutical and medical device companies, with $16.93 received in 2022. These payments were reported across 22 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($361.83).

As a Medicare-enrolled provider, St. John has provided services to 1,209 Medicare beneficiaries, totaling 1,683 services with total Medicare billing of $98,438. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Registered Nurse
  • Other Specialties Nurse Practitioner, Adult Health
  • Location Orlando, FL
  • Active Since 09/05/2019
  • Last Updated 09/19/2024
  • Taxonomy Code 163W00000X
  • Entity Type Individual
  • NPI Number 1447809256

Products in Payments

  • STELARA (Biological) $122.68
  • HUMIRA (Biological) $96.27
  • LINZESS (Drug) $56.35
  • OCALIVA (Drug) $40.81
  • XIFAXAN (Drug) $32.55
  • MOTEGRITY (Drug) $21.99
  • ZEPOSIA (Drug) $19.98
  • XELJANZ (Drug) $19.62
  • CIMZIA (Drug) $18.00
  • RAS-45 RRa Adult/Pediatric Acoustic Respiration Sensor (Device) $16.93
  • VIBERZI (Drug) $16.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Registered Nurse Doctors in Orlando